Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. reports developments in science-based nutraceutical supplements, oral delivery technology, and precision-dose gummy manufacturing. The company develops, manufactures, and markets proprietary supplements for brain, heart, and gut health, with product formats that include gel packs, functional drinking straws, and gummies through its Gummy USA subsidiary.
Recurring company news includes revenue updates, direct-to-consumer and retail sales activity, Amazon subscription trends, product launches such as STAT10 and 4Sleep, and B2B manufacturing relationships for private-label and branded gummy products. Coverage also reflects the completed Gummy USA combination, which added a HACCP, GMP-certified and FDA-registered manufacturing facility to the company’s nutraceutical platform.
Healthy Extracts (OTCQB:HYEX) acquired Imaraïs Beauty, a women’s health and beauty gummy brand co-founded by Sommer Ray.
The deal marks entry into the $730 billion beauty and personal care market and raises the company’s 2026 annualized revenue run-rate outlook by 20% to more than $24 million.
Imaraïs adds globally distributed functional beauty gummies, with an initial order of 4 million gummies across five SKUs and new leadership roles for co-founder Aaron Hefter.
Healthy Extracts (OTCQB:GELS) reported record Q1 2026 net revenue of $1.6 million, up 73% year over year, driven largely by the Gummy USA merger and broader distribution.
Gross profit rose 133% to $989,000 with 61.4% margin, net loss narrowed to $201,000, and EBITDA turned positive at $40,500. Management is targeting 2026 net revenue above $20 million, supported by a major Imaraïs Beauty manufacturing partnership and Gummy USA’s facility, which is expected to reach its $20 million annual production capacity.
Healthy Extracts (OTCQB:HYEX) announced on April 16, 2026 that its subsidiary Gummy USA secured a U.S. manufacturing partnership with Imaraïs Beauty, launching with an initial order of nearly 4 million gummies across five SKUs for distribution to 4,800+ store locations with isle end-cap placements.
The collaboration leverages Imaraïs' retail footprint (Target, Ulta, Sprouts) and an influencer reach of 40 million followers, targeting rapid expansion in the $720 billion health & beauty market and scaling Gummy USA's manufacturing output for the year.
Healthy Extracts (OTCQB:HYEX) reported record 2025 results with net revenue up 45% to $4.5M driven largely by the merger with Gummy USA, product launches and expanded DTC and retail channels. Gross profit rose 27% to $2.4M (53.7% margin). GAAP net loss was $881,000; non-GAAP net income was $162,000 or $0.02 per share. Management projects 2026 net revenues could exceed $20M, reflecting anticipated ramp at Gummy USA's facility and expanded product commercialization.
Healthy Extracts (OTCQB:GELS) reported preliminary unaudited 2025 results showing net revenue up 45% to $4.5 million, driven by the Gummy USA merger, product launches, and channel expansion. Organic operations grew ~25% and subscription channels rose substantially, while management projects the new facility could reach a $20 million annual capacity in 2026.
Results are preliminary and subject to audit and revision before the company's Form 10-K filing.
Healthy Extracts (OTCQB:HYEX) reported record third-quarter and nine-month 2025 revenue driven by product launches and channel expansion. Q3 revenue rose 23% to $918,000 and 9M revenue rose 20% to $2.8M. Gross profit fell 26% in Q3 to $447,000 (48.7% margin) due to higher supply chain and raw material costs. Operating expenses increased 75% in Q3 to $907,000, partly from one-time merger and stock-for-services costs. Net loss was $395,000 (‑$0.06) in Q3 versus net income a year earlier. On October 1 the company completed a merger with Gummy USA, secured a 6 million gummy follow-on order, and said the new facility could reach $20M annual capacity in 2026. Cash was $189,000 at Sept 30. Management expects annualized net revenue >$11.5M by year-end.
Healthy Extracts (OTCQB:HYEX) was invited to present at the Trickle Research Microcap Conference on November 13, 2025 at Topgolf Centennial in Centennial, Colorado, with a live stream scheduled and a 3:06 p.m. Mountain time presentation.
Management will review the company platform, recent merger with Gummy USA completed in early October, and product growth: Q3 2025 net revenue expected +23% YoY, direct-to-consumer subscriptions +58%, Amazon Subscribe & Save orders +98%, and a 6 million gummy follow-on order contributing to a projected record Q4 and full year.
Healthy Extracts (OTCQB:HYEX) expects Q3 2025 net revenue of ~ $920,000, up 23% year-over-year and the highest third-quarter result on record.
Subscription growth drove results: Amazon "Subscribe & Save" customers rose 98% and direct-to-consumer subscriptions rose 58%. The company completed a merger with Gummy USA effective at the start of Q4 and announced a follow-on order for 6 million nutraceutical gummies expected to significantly boost Q4 revenue. New product launches in Q3 expanded categories to include sleep and gut health. Results are preliminary, unaudited and subject to revision ahead of the official Q3 report in November.
Healthy Extracts (OTCQB: HYEX) announced that its Gummy USA subsidiary received a 6 million gummy follow-on order for a proprietary women's formulation, scheduled to ship within four weeks. The gummies target hormonal-balance symptoms such as missed periods, acne, excess hair growth, infertility and weight gain and were developed with client medical advisors. Gummy USA cites selection over competitors for superior texture and flavor with challenging ingredients and says its HACCP, GMP-certified, FDA-registered facility is scaling to meet rising private-label demand. The company references a recent merger integrating R&D, manufacturing, distribution and sales.
Healthy Extracts (OTCQB:HYEX) announced significant developments following its merger with Gummy USA, as discussed by new CEO Don Swanson in a Money Channel interview. The merger integrates Gummy USA's proprietary SureDose™ technology with Healthy Extracts' product development and marketing platform.
The company reported strong financial performance with net revenues up 20% in H1 2025. Notable growth metrics include 88% increase in direct-to-consumer subscriptions and 107% growth in Amazon Subscribe & Save customers. The merger is expected to accelerate growth by over 50% in the coming year.